ClinicalTrials.gg
RecruitingNCT07236866GRAMPAUpdated Mar 18, 2026

Evaluation of GRAMPA Score Measuring Motor Abilities of Elderly Patients

An interventional study of GRAMPA scale in Geriatric Assessment, sponsored by Groupe Hospitalier Mutualiste de Grenoble. Recruiting at 2 sites in France. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2026-03-18.

Sponsored by Groupe Hospitalier Mutualiste de Grenoble · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Nov 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Not applicable
Ages
75 Years and older
Sex
All
01

Study summary

In the field of geriatrics, the Standardized Geriatric Approach (SGA) which is the benchmark for assessing elderly patients, consists of evaluating the medical, psychological and functional capacity dimensions of the elderly subject, among others.

After a review of the literature, investigators were unable to find any scales that could study the ability to perform basic movements in a comprehensive and graded manner.

Scores that do assess certain aspects of motor abilities are not comprehensive, and are often based on self-reporting by the elderly or their relatives :

  • The AGGIR grid assesses dependency on the basis of activities performed or not performed. In addition, all basic movements are grouped together in a single item, which does not provide detailed information on the capabilities of elderly people.
  • The ADL score assesses activities of daily living, based on what patients declare. Only one item concerns basic movements, without detailing them.
  • The Tinetti score and Time up and go do not assess all basic movements, and require the patient to be able to stand to provide relevant information, whereas many geriatrics patients are unable to stand.

Thus, investigators created a score to assess motor abilities more comprehensively that will include the following basic movements:

  • Getting up in bed
  • Turning on one side in bed
  • Sitting at the edge of the bed
  • Stand up
  • Move around a small perimeter (bedroom)
  • Sitting up
  • Return to bed

The main objective is to evaluate of this study is to determine the inter-rater reliability of the GRAMPA score in elderly patients hospitalized in a geriatrics department.

Read the detailed description

In the field of geriatrics, the Standardized Geriatric Approach (SGA) which is the benchmark for assessing elderly patients, consists of evaluating the medical, psychological and functional capacity dimensions of the elderly subject, among others. This approach is defined as a "multidimensional and interdisciplinary diagnostic process that seeks to assess the medical, psychological and functional capacity of the frail elderly person, with the aim of developing a coordinated and integrated long-term treatment and follow-up plan".

Mobility or functional capacity, an essential component of AGS, is generally studied in terms of balance, walking and basic movement, as in the Tinetti tests, the Timed up and go or walking speed. According to the French National Authority for Health (HAS), "the ability to perform basic movements largely determines the level of physical dependence. The important stages in assessing mobility and the quality of the strategies used are: raising in bed, turning on one side in bed, getting out of bed, moving from sitting to standing and from standing to sitting'.

After a review of the literature, investigators were unable to find any scales that could study the ability to perform basic movements in a comprehensive and graded manner. The Minimum Motor Test (MMT), a score created in 2005 with the aim of observing motor abilities and establishing rehabilitation objectives for patients suffering from psychomotor maladjustment syndrome, does not allow exhaustive evaluation of basic movements and is not very sensitive for distinguishing between two patients unable to hold the standing position (15 items /20 requiring standing). In particular, it does not include bed raising and sit-to-stand transfers. The test is based on clinical observations using two scoring levels: if the answer to the question asked is 'yes', the score awarded is 1; if the answer is 'no', the score awarded is 0. The maximum total score that can be obtained is 20. A high score means that good physical ability has been retained.

The AGGIR grid assesses dependency on the basis of activities performed or not performed. In addition, all basic movements are grouped together in a single item, which does not provide detailed information on the capabilities of elderly people.

The Activities of Daily Living (ADL) assesses independence in activities of daily living in the broadest sense, but does not specifically target functional motor skills. A score of 6 determines the maximum level of autonomy. The overall score varies from 0 (totally dependent) to 6 (best possible independence). Measuring ADLs is relevant for all elderly people, regardless of where they live.

Thus, investigators created a score, the GRAMPA score, to assess motor abilities more comprehensively that will include the following basic movements:

  • Getting up in bed
  • Turning on one side in bed
  • Sitting at the edge of the bed
  • Stand up
  • Move around a small perimeter (bedroom)
  • Sitting up
  • Return to bed

In the GRAMPA score, these basic movements are characterised according to 3 grades of autonomy:

  • Unassisted: The patient carries out the basic movement alone, without technical aid or verbal guidance.
  • Partial assistance: The patient needs technical assistance, i.e. equipment, and/or verbal guidance to carry out the basic movement.
  • Significant assistance: The patient needs human assistance to carry out the basic movement, i.e. as soon as the carer puts his/her hands on the patient to mobilise or support him/her, and/or the carer handles the heavy equipment needed to carry out the transfer.

Investigators believe that the GRAMPA score (GRaduation de l'Autonomie Motrice des Personnes Agées) would be a better reflection of the motor abilities of elderly subjects, by studying their ability to move in a restricted environment (e.g. a hospital room).

A more accurate estimate of basic functional motor skills would help to improve communication between healthcare professionals and optimise treatment by adapting strategies to the patient's level of functional autonomy (patient dependence in terms of equipment layout, rehabilitation objectives and limiting iatrogenic dependence).

As the metrological qualities of the score have not been validated, it will not be used to modify the management of patients included in the study.

There will therefore be no significant benefit or risk for participating patients.

Patients' motor skills are information that is communicated very regularly between healthcare professionals, and which is essential for helping patients regain their independence and organising care in a rehabilitation department. In particular, this information can be used to choose the technical aids best suited to patients' autonomy, or to decide on the possibility of a return home.

In particular, this score would enable better inter-professional communication about patients' functional abilities, leading to improved conditions for patient care by professionals.

02

Conditions studied

  • Geriatric Assessment

Keywords

  • motor skills
  • rehabilitation
03

In context

Lead sponsor

Groupe Hospitalier Mutualiste de Grenoble is the lead sponsor of 12 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
75 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age ≥ 75 years
  2. Patients hospitalized in the geriatrics department of the Grenoble Mutualist Hospital Group
  3. Comprehension of the French language (understanding of instructions)
  4. Signature of free and

Exclusion criteria

Exclusion Criteria:

  1. Patients whose sensory and/or mental capacities do not allow them to understand the instructions for carrying out transfers.
  2. Patients with medical or surgical making it impossible to carry out transfers.
  3. Patients under legal protection or unable to express their consent.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
55 participants (estimated)

Study arms

  • Experimental
    Scales Motricity

    The motor skills will be assessed using the GRAMPA scale and compared with the scales usually used in current practice: the minimum motor test (TMM) and the Katz scale (ADL). The GRAMPA scale will be carried out : * At admission * During the hospitalisation by two different physiotherapist * At discharge

    Other: GRAMPA scale

Interventions

  • OtherGRAMPA scale

    The GRAMPA scale will be carried out for every patient. The patient will be asked to do the following basic movement, in an order defined by the physiotherapist: * Get back into bed * Turn on the side in bed * Sit on the edge of the bed * Stand up * Move around the room * Sitting up * Getting back into bed It takes around 5 to 10 minutes to complete the scale

06

What researchers measure

Primary outcomes

  1. Assess the inter-rater reliability of the Motor Autonomy Assessment for the Elderly (GRAMPA) score.

    Intra-class correlation coefficient (ICC). The score will therefore be calculated by 2 different professionals on the same patient during hospitalisation. Score total GRAMPA \[0;14\] , Score \[0-5\] significant help, Score \[6-11\] = partial assistance, Score \[12-14\] = unaided

    Time frame: Peri-interventional

Secondary outcomes

  1. Assess the convergent validity of the GRAMPA score against two established scales: Mini Moteur Test and Activities of Daily Living.

    Correlation coefficient calculated between the GRAMPA score and each of the two scales Total TMM score \[0;20\] A high score means good physical; ADL Score 6=independent, 4=moderate impairment, 0= very dependent

    Time frame: Baseline

  2. Assess the convergent validity of the GRAMPA score against two established scales: Mini Moteur Test and Activities of Daily Living.

    Correlation coefficient calculated between the GRAMPA score and each of the two scales Total TMM score \[0;20\] A high score means good physical; ADL Score 6=independent, 4=moderate impairment, 0= very dependent

    Time frame: the end of the study i.e. 3 weeks on average

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2025 (actual). Primary completion is estimated for Nov 2027, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 27, 2025
First posted
Nov 19, 2025
StartActual
Nov 7, 2025
Primary completionEst.
Nov 1, 2027
CompletionEst.
Nov 1, 2027
Last update
Mar 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07236866
Lead sponsor
Groupe Hospitalier Mutualiste de Grenoble
Responsible party
Sponsor
First posted
Nov 19, 2025
Start date
Nov 7, 2025
Primary completion
Nov 1, 2027 (estimated)
Completion
Nov 1, 2027 (estimated)
Last update
Mar 18, 2026

Study contacts

Steve SO Odezenne, physiotherapist
Contact
steve.odezenne@ghm-grenoble.fr
0033 4.76.70.70.00 ext. 7252
Charlotte CM Mathon, doctor
Contact
charlotte.mathon@ghm-grenoble.fr
00 33 4.76.70.70.00 ext. 70 60

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion